Lechleiter to Address Life Sciences Summit

October 23, 2012

News Release

INDIANAPOLIS, Ind. -

Indiana Life Sciences Summit Tues., October 23, 2012
Westin, downtown Indianapolis

We have an all-star lineup of speakers for the upcoming Indiana Life Sciences Summit. You won't want to miss these thought leaders as they discuss and speak on timely and pertinent topics that will shape the future of Indiana's life sciences industry.

We are excited to announce the following experts and panel topics:

Keynote Address: Pharmaceutical Industry Innovation
John Lechleiter, Ph.D. — President, Chairman and Chief Executive Officer of Eli Lilly and Company, Chairman, Pharmaceutical Research and Manufacturers of America

Discovering Smarter Ways to Lead Innovation

Brian Rye- Healthcare Financial Analyst, Bloomberg Government

Mike Sherman- Chief Financial Officer, Endocyte

Deb Tanner- Executive Vice President and Group President, Research & Development Laboratories, Covance, Inc.

BIll Ringo- Adviser, Sofinnova Ventures; former Senior Vice President, Pfizer

David Broecker- President, Research Models & Services, Harlan Laboratories

The Opportunities and Challenges of Advancing Innovation in the Medical Device and Technology Sector

Sheryl Conley- Chief Executive Officer, OrthoWorx

Mark Bleyer- President, Cook Biotech

Hans-Juergen Loyda- Director of Clinical Development and Education, Roche Diagnostics North America

John Hertig- Executive Director, Alfred Mann Institute at Purdue University

Cheryl Blanchard- Former Senior Vice President, Chief Scientific Officer, Zimmer

Capitalizing in the Current Market: VCs and Entrepreneurs Talk Shop

Ron Hunt -- Managing Director, New Leaf Venture Partners

Jonathan Silverstein- General Partner, OrbiMed

Bernard Yancovich- Managing Partner, Credit Suisse

Kristin Sherman- Financial Advisor, AgeneBio; former Chief Financial Officer, Marcadia Biotech

Adele Oliva- Partner, Quaker Partners

Source: BioCrossroads